Blend Labs, Inc. (BLND)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-09
$1.42-4.70%
Close 2026-09-09 · 1-day change
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-09
Broken: Primary pillar broken — Non-GAAP operating income >= $5.5M in Q2 2026: Non-GAAP operating income $0.0M vs $5.5M target.
Blend aims for positive operating income with $6.5M in Q2 2026. Revenue should grow to $34M in Q2 2026. The company started a $50M share buyback to boost value. Recent earnings beats show progress on growth and costs.
Blend is still loss-making and faces high risk. Revenue growth may slow below 10%. Share buyback may not offset weak profits. Analyst estimates have been cut recently.
The price is about 16% below our fair value near $2. Analysts expect 10% revenue growth. Our fair value is 38% below the Street median, showing caution.
Breaks if: Non-GAAP operating income falls below $5.5M in Q2 2026
Continue improving operational efficiency to reach and sustain positive non-GAAP operating income.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a medium confidence level. BLND is currently loss-making but is working towards achieving positive operating income and consistent revenue growth.
The market seems to have priced in a low expectations gap, indicating that investors are not overly optimistic about immediate performance. Valuation appears aligned with peers, but BLND carries a premium compared to them.
Management has shown stability and is on track with its priorities, including improving operational profitability and revenue. However, the company remains in a high-risk environment, with recent financial performance being neutral and slightly below industry peers.
The future performance of BLND hinges on management's ability to maintain revenue growth and achieve positive non-GAAP operating income. Additionally, external factors like potential interest rate cuts and the performance of sector bellwethers will play a significant role.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Non-GAAP operating income improved from $0.7M in 2025-Q1 to $4.1M in 2026-Q1 and further to $7.0M in 2026-Q2, exceeding guidance. Management is delivering on improving operational profitability.
“Non-GAAP operating income above the high end of our guidance”
“Non-GAAP operating income both above the high end of guidance”
“Non-GAAP Net Operating Income $2.5M - $3.5M guidance provided”
Breaks if: Revenue falls below $32M in Q2 2026
Grow total revenue to the guided range of $32 million to $34 million in the second quarter of 2026.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $26.8M in 2025-Q1 to $30.8M in 2026-Q1 and reached $33.8M in 2026-Q2, near the high end of guidance. Management is delivering consistent revenue growth aligned with targets.
“Total revenue near the high end of guidance at $33.8 million”
“First quarter revenue was $30.8 million, an increase of 15% year-over-year”
“Guidance for Q4 2025 revenue $31.0M - $32.5M”
Breaks if: Buyback program is canceled or materially delayed
Execute the authorized $50 million share repurchase program to return capital to shareholders.
Stated as a priority in 2 of last 3 quarters. Management repurchased 11.2 million shares for $18.6M in 2026-Q1 and 11.0 million shares for $18.2M in 2026-Q2 under the $50M authorization. The program is actively executed with substantial capital returned.
“Repurchased 11.0 million shares for $18.2 million in Q2 2026”
“Repurchased 11.2 million shares for $18.6 million in Q1 2026”
Over the next 1 to 3 years, BLND's trajectory will depend on its operational execution and broader market conditions. Not investment advice.